Stem cell therapy

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Revision as of 08:29, April 2, 2023 by Notjusttired (talk | contribs) (Text replacement - "| author-link= |" to "| author-link = |")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Stem cell therapy, in particular the use of mesenchymal stromal cells (MSCs) is a potential treatment that has been suggested for ME/CFS.[1]

Theory[edit | edit source]

Diagram showing stimulated, suppressed and inhibited effects on immune system.
iDC, immature dendritic cell; IL, interleukin;
HGF, hepatocyte growth factor;
TGF-β, transforming growth factor-β;
PGE-2, prostaglandin E2; IDO, indoleamine-2,3-dioxygenase;
NO, nitric oxide; PD-L1, programmed death-ligand 1;
hMSC, human mesenchymal stem cell;
Treg, T regulatory; Th, T helper cell
CTL, cytotoxic T cell; mDC, mature dendritic cell
PD-1, programmed cell death protein ;1
PMN, polymorphonuclear leukocyte;
NK, Natural killer cell

Evidence[edit | edit source]

Clinical trials of stem cell therapies have not yet been published.[1]

Clinicians[edit | edit source]

Risks and safety[edit | edit source]

Costs and availability[edit | edit source]

See also[edit | edit source]

Learn more[edit | edit source]

References[edit | edit source]